KRT32

gene
On this page

Also known as Ha-2

Summary

KRT32 (keratin 32, HGNC:6449) is a protein-coding gene on chromosome 17q21.2, encoding Keratin, type I cuticular Ha2 (Q14532).

The protein encoded by this gene is a member of the keratin gene family. As a type I hair keratin, it is an acidic protein which heterodimerizes with type II keratins to form hair and nails. The type I hair keratins are clustered in a region of chromosome 17q12-q21 and have the same direction of transcription.

Source: NCBI Gene 3882 — RefSeq curated summary.

At a glance

  • Clinical variants (ClinVar): 74 total
  • MANE Select transcript: NM_002278

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:6449
Approved symbolKRT32
Namekeratin 32
Location17q21.2
Locus typegene with protein product
StatusApproved
AliasesHa-2
Ensembl geneENSG00000108759
Ensembl biotypeprotein_coding
OMIM602760
Entrez3882

Gene structure

Transcript identifiers

Ensembl transcripts: 1 — 1 protein_coding

ENST00000225899

RefSeq mRNA: 1 — MANE Select: NM_002278 NM_002278

CCDS: CCDS11393

Canonical transcript exons

ENST00000225899 — 7 exons

ExonStartEnd
ENSE000007226504146407841464203
ENSE000011183954145951341460239
ENSE000011183964146685841467386
ENSE000023471414146609441466176
ENSE000023756224146283041463050
ENSE000023924544146577341465929
ENSE000023939704146428241464443

Expression profiles

Bgee: expression breadth broad, 48 present calls, max score 81.84.

Top tissues by expression

270 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
hair follicleUBERON:000207381.84gold quality
cervix squamous epitheliumUBERON:000692280.25gold quality
lower esophagus mucosaUBERON:003583478.35gold quality
tongue squamous epitheliumUBERON:000691975.23gold quality
upper arm skinUBERON:000426373.60silver quality
spermCL:000001973.43gold quality
esophagus mucosaUBERON:000246971.72gold quality
male germ cellCL:000001571.56gold quality
squamous epitheliumUBERON:000691469.89gold quality
diaphragmUBERON:000110369.87gold quality
orbitofrontal cortexUBERON:000416769.13gold quality
tibialis anteriorUBERON:000138569.08silver quality
periodontal ligamentUBERON:000826668.77silver quality
epithelium of esophagusUBERON:000197668.50silver quality
esophagus squamous epitheliumUBERON:000692067.78silver quality
endometrium epitheliumUBERON:000481166.87gold quality
oocyteCL:000002365.50gold quality
cervix epitheliumUBERON:000480165.29gold quality
endothelial cellCL:000011564.95gold quality
gingival epitheliumUBERON:000194963.77gold quality
secondary oocyteCL:000065563.65gold quality
skeletal muscle tissue of rectus abdominisUBERON:000451163.49gold quality
gingivaUBERON:000182862.20gold quality
tendon of biceps brachiiUBERON:000818862.12gold quality
deltoidUBERON:000147661.27gold quality
gluteal muscleUBERON:000200060.99gold quality
triceps brachiiUBERON:000150960.90gold quality
quadriceps femorisUBERON:000137760.33gold quality
nippleUBERON:000203059.52silver quality
cartilage tissueUBERON:000241859.52gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 0.

ExperimentMarker?Max mean expression
E-ANND-3no3.27

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

34 targeting KRT32, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-4795-3P100.0074.624024
HSA-MIR-314899.9775.066478
HSA-MIR-6793-5P99.9765.95758
HSA-MIR-607999.8468.541170
HSA-MIR-205299.7969.372031
HSA-MIR-34B-5P99.7867.561175
HSA-MIR-449C-5P99.7867.631168
HSA-MIR-2682-5P99.7367.381055
HSA-MIR-4524A-3P99.7266.852406
HSA-MIR-182799.6368.573265
HSA-MIR-3616-5P99.5567.02989
HSA-MIR-57399.5567.44955
HSA-MIR-312899.5067.851258
HSA-MIR-6828-5P99.3169.211433
HSA-MIR-472199.2666.05818
HSA-MIR-450499.1069.141328
HSA-MIR-6868-5P99.0665.691284
HSA-MIR-6877-3P98.9865.83560
HSA-MIR-6819-3P98.9565.57572
HSA-MIR-181A-2-3P98.9167.601168
HSA-MIR-629-5P98.7868.721032
HSA-MIR-331-3P98.7664.91793
HSA-MIR-427597.9668.421549
HSA-MIR-4799-3P97.7865.97893
HSA-MIR-4723-3P97.6765.911017
HSA-MIR-805797.6466.54897
HSA-MIR-4720-5P97.4665.67893
HSA-MIR-5588-5P97.4665.70913
HSA-MIR-6769B-3P97.4165.531036
HSA-MIR-318397.4065.68978

Cross-species orthologs

2 orthologs

OrganismSymbolGene ID
mus_musculusKrt32ENSMUSG00000046095
rattus_norvegicusKrt32ENSRNOG00000013611

Paralogs (68): KRT33A (ENSG00000006059), VIM (ENSG00000026025), KRT31 (ENSG00000094796), NEFM (ENSG00000104722), KRT23 (ENSG00000108244), KRT37 (ENSG00000108417), KRT18 (ENSG00000111057), LMNB1 (ENSG00000113368), KRT36 (ENSG00000126337), KRT17 (ENSG00000128422), GFAP (ENSG00000131095), KRT34 (ENSG00000131737), KRT33B (ENSG00000131738), NES (ENSG00000132688), PRPH (ENSG00000135406), KRT85 (ENSG00000135443), KRT7 (ENSG00000135480), KRT71 (ENSG00000139648), INA (ENSG00000148798), LMNTD1 (ENSG00000152936), LMNA (ENSG00000160789), KRT84 (ENSG00000161849), KRT82 (ENSG00000161850), KRT80 (ENSG00000167767), KRT1 (ENSG00000167768), KRT24 (ENSG00000167916), KRT8 (ENSG00000170421), KRT78 (ENSG00000170423), KRT86 (ENSG00000170442), KRT75 (ENSG00000170454), KRT6C (ENSG00000170465), KRT4 (ENSG00000170477), KRT74 (ENSG00000170484), KRT72 (ENSG00000170486), KRT83 (ENSG00000170523), BFSP2 (ENSG00000170819), KRT19 (ENSG00000171345), KRT15 (ENSG00000171346), KRT38 (ENSG00000171360), KRT13 (ENSG00000171401)

Protein

Protein identifiers

Keratin, type I cuticular Ha2Q14532 (reviewed: Q14532)

Alternative names: Hair keratin, type I Ha2, Keratin-32

All UniProt accessions (1): Q14532

UniProt curated annotations — full annotation on UniProt →

Tissue specificity. Restricted to the hair cuticle.

Miscellaneous. There are two types of hair/microfibrillar keratin, I (acidic) and II (neutral to basic).

Similarity. Belongs to the intermediate filament family.

RefSeq proteins (1): NP_002269* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR002957Keratin_IFamily
IPR009030Growth_fac_rcpt_cys_sfHomologous_superfamily
IPR018039IF_conservedConserved_site
IPR039008IF_rod_domDomain

Pfam: PF00038

UniProt features (23 total): sequence variant 11, region of interest 7, sequence conflict 2, chain 1, domain 1, site 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q14532-F176.820.58

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Catalytic / active sites (1): 345 (stutter)

Function

Pathways and Gene Ontology

Reactome pathways

3 pathways

IDPathway
R-HSA-6805567Keratinization
R-HSA-6809371Formation of the cornified envelope
R-HSA-1266738Developmental Biology

MSigDB gene sets: 116 (showing top): GOBP_MORPHOGENESIS_OF_AN_EPITHELIUM, GOBP_EPITHELIUM_DEVELOPMENT, GOBP_INTERMEDIATE_FILAMENT_BASED_PROCESS, YAGI_AML_WITH_INV_16_TRANSLOCATION, GOBP_INTERMEDIATE_FILAMENT_ORGANIZATION, LHX3_01, SHEPARD_BMYB_MORPHOLINO_DN, GCM_PRKCG, TCF4_Q5, GCM_RING1, NKX62_Q2, MODULE_379, MARTINEZ_RB1_TARGETS_DN, OCT1_03, MODULE_298

GO Biological Process (4): morphogenesis of an epithelium (GO:0002009), epidermis development (GO:0008544), epithelial cell differentiation (GO:0030855), intermediate filament organization (GO:0045109)

GO Molecular Function (3): structural constituent of skin epidermis (GO:0030280), structural molecule activity (GO:0005198), protein binding (GO:0005515)

GO Cellular Component (5): cytosol (GO:0005829), cytoskeleton (GO:0005856), keratin filament (GO:0045095), extracellular exosome (GO:0070062), intermediate filament (GO:0005882)

Reactome top-level categories

Rollup of top-2 pathways:

CategoryPathways
Developmental Biology1
Keratinization1

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
epithelium development2
tissue morphogenesis1
tissue development1
cell differentiation1
intermediate filament cytoskeleton organization1
supramolecular fiber organization1
structural molecule activity1
molecular_function1
binding1
cytoplasm1
cellular anatomical structure1
intracellular membraneless organelle1
intermediate filament1
extracellular vesicle1
intermediate filament cytoskeleton1
polymeric cytoskeletal fiber1

Protein interactions and networks

STRING

462 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
KRT32MSX2P35548494
KRT32CRNNQ9UBG3479
KRT32HOXC12P31275418
KRT32KRTAP3-3Q9BYR6406
KRT32KRTAP11-1Q8IUC1394
KRT32PRORPO15091392
KRT32OR8K3Q8NH51352
KRT32KRTAP4-1Q9BYQ7352
KRT32MSANTD4Q8NCY6346
KRT32HOXC13P31276336
KRT32CCDC117Q8IWD4332
KRT32KRTAP3-2Q9BYR7331
KRT32OVOL1O14753325
KRT32ADPRMQ3LIE5324
KRT32KRTAP6-2Q3LI66323

IntAct

42 interactions, top by confidence:

ABTypeScore
KRT32KRT80psi-mi:“MI:0915”(physical association)0.600
KRT32KRT72psi-mi:“MI:0915”(physical association)0.560
KRT86KRT32psi-mi:“MI:0915”(physical association)0.560
KRT32TCHPpsi-mi:“MI:0915”(physical association)0.560
KRT32GATAD2Apsi-mi:“MI:0915”(physical association)0.560
KRT32MGC50722psi-mi:“MI:0915”(physical association)0.560
UBASH3AKRT32psi-mi:“MI:0915”(physical association)0.560
KRT32KIFC3psi-mi:“MI:0915”(physical association)0.560
NEDD9KRT32psi-mi:“MI:0915”(physical association)0.560
repKRT32psi-mi:“MI:0915”(physical association)0.560
PPP2R2BDDX3Xpsi-mi:“MI:0914”(association)0.460
WTAPDDX39Apsi-mi:“MI:0914”(association)0.350
AKT3AKT2psi-mi:“MI:0914”(association)0.350
AKT1S100A3psi-mi:“MI:0914”(association)0.350
KRT32THAP12psi-mi:“MI:0914”(association)0.350
SULF2IGHA1psi-mi:“MI:0914”(association)0.350
psi-mi:“MI:0914”(association)0.350
FHIP1AILVBLpsi-mi:“MI:2364”(proximity)0.270
CDC20KRT32psi-mi:“MI:0915”(physical association)0.000
CDK12KRT32psi-mi:“MI:0915”(physical association)0.000
KRT72KRT32psi-mi:“MI:0915”(physical association)0.000
KRT86KRT32psi-mi:“MI:0915”(physical association)0.000
TCHPKRT32psi-mi:“MI:0915”(physical association)0.000
KIFC3KRT32psi-mi:“MI:0915”(physical association)0.000
NEDD9KRT32psi-mi:“MI:0915”(physical association)0.000
KRT80KRT32psi-mi:“MI:0915”(physical association)0.000

BioGRID (43): KRT32 (Synthetic Lethality), KRT32 (Affinity Capture-MS), KRT32 (Affinity Capture-MS), KRT32 (Affinity Capture-MS), KRT32 (Affinity Capture-MS), KRT32 (Proximity Label-MS), KRT32 (Affinity Capture-MS), NEDD9 (Two-hybrid), TCHP (Two-hybrid), KIFC3 (Two-hybrid), UBASH3A (Two-hybrid), GATAD2A (Two-hybrid), KRT80 (Two-hybrid), KRT86 (Two-hybrid), KRT72 (Two-hybrid)

ESM2 similar proteins: A4FUZ0, A5A6M5, A5A6P3, A6QNX5, A7YWK3, B0LKP1, B1AQ75, E1AB55, O43790, O76009, O76013, P02534, P15241, P19013, P25690, P25691, P78385, P78386, P97861, Q0P5J7, Q14525, Q14532, Q14533, Q148H4, Q148H5, Q148H7, Q148H8, Q14CN4, Q15323, Q3SY84, Q497I4, Q61765, Q61897, Q62168, Q6IG03, Q6IG04, Q6IME9, Q6IMF0, Q6NXH9, Q86Y46

Diamond homologs: A1KQY9, A1L317, A1L595, A5A6M0, A5A6M5, A5A6N2, A5A6P3, A6BLY7, A6QQQ9, A7YWM2, B0LKP1, B1AQ75, O57607, O57611, O76009, O76013, O77727, O93256, P02533, P02534, P02535, P02537, P05781, P05783, P05784, P06394, P08727, P08728, P08730, P08777, P08778, P08779, P08802, P13645, P13646, P19001, P19012, P25030, P25690, P35527

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

74 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance72
Likely benign1
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

857 predictions. Top by Δscore:

VariantEffectΔscore
17:41462815:G:Cdonor_gain1.0000
17:41462828:A:ACdonor_gain1.0000
17:41462829:C:Adonor_loss1.0000
17:41462829:C:CTdonor_gain1.0000
17:41462829:CTTG:Cdonor_gain1.0000
17:41462836:T:TAdonor_gain1.0000
17:41463046:TCCCT:Tacceptor_gain1.0000
17:41463047:CCCT:Cacceptor_gain1.0000
17:41463047:CCCTC:Cacceptor_gain1.0000
17:41463048:CCTC:Cacceptor_gain1.0000
17:41463048:CCTCT:Cacceptor_loss1.0000
17:41463049:CT:Cacceptor_gain1.0000
17:41463051:C:CCacceptor_gain1.0000
17:41463057:C:CTacceptor_gain1.0000
17:41463058:A:Tacceptor_gain1.0000
17:41464072:TCTCA:Tdonor_loss1.0000
17:41464073:CTCAC:Cdonor_loss1.0000
17:41464074:TCACC:Tdonor_loss1.0000
17:41464075:CACC:Cdonor_loss1.0000
17:41464076:A:ACdonor_gain1.0000
17:41464077:C:CCdonor_gain1.0000
17:41464077:CCAGG:Cdonor_gain1.0000
17:41464204:C:CCacceptor_gain1.0000
17:41464208:A:Tacceptor_gain1.0000
17:41464277:CCCA:Cdonor_loss1.0000
17:41464278:CCA:Cdonor_loss1.0000
17:41464279:CA:Cdonor_loss1.0000
17:41464281:C:CTdonor_loss1.0000
17:41464298:T:Adonor_gain1.0000
17:41464307:T:TAdonor_gain1.0000

AlphaMissense

2942 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
17:41464097:A:GL326P0.994
17:41464092:C:GA328P0.988
17:41467009:C:GR106P0.988
17:41464130:A:GL315P0.986
17:41465855:A:GL209P0.986
17:41464291:G:CF287L0.985
17:41464291:G:TF287L0.985
17:41464293:A:GF287L0.985
17:41465834:A:GL216P0.984
17:41464346:C:GR269P0.982
17:41465813:A:GL223P0.982
17:41466113:C:GA178P0.982
17:41462869:A:GI393T0.981
17:41465792:A:GL230P0.981
17:41465801:A:GL227P0.981
17:41462932:A:GL372P0.979
17:41464079:A:GL332P0.978
17:41464193:A:GL294P0.978
17:41466125:C:GA174P0.976
17:41464088:T:GQ329P0.975
17:41466994:A:GL111P0.974
17:41467006:A:GL107P0.974
17:41462953:A:GL365P0.973
17:41462851:A:GL399P0.972
17:41462861:A:GY396H0.972
17:41462869:A:CI393S0.972
17:41462881:A:GL389P0.972
17:41465906:C:GR192P0.971
17:41462857:C:GR397P0.970
17:41462861:A:CY396D0.970

dbSNP variants (sampled 300 via entrez): RS1000275820 (17:41461852 G>T), RS1000686036 (17:41467973 T>C), RS1000709323 (17:41462235 T>A), RS1000762442 (17:41468204 C>A,T), RS1000904388 (17:41463459 C>T), RS1000992271 (17:41460428 C>G), RS1001317471 (17:41459204 G>T), RS1001450929 (17:41468184 A>G), RS1001662815 (17:41464496 C>T), RS1002930043 (17:41465698 G>A,T), RS1003248072 (17:41461541 G>A), RS1003265649 (17:41465496 T>C), RS1003321654 (17:41461796 A>T), RS1003450810 (17:41459191 T>C), RS1004503425 (17:41469357 T>C)

Disease associations

OMIM: gene MIM:602760 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

0 associations (top):

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

11 total (human), top 11 by PubMed support.

ChemicalActions (top 5)PubMed papers
decabromobiphenyl etheraffects expression1
sodium arseniteincreases expression1
CGP 52608affects binding, increases reaction1
Resveratrolaffects cotreatment, decreases expression1
Azacitidineincreases expression1
Benzo(a)pyreneincreases methylation, affects methylation1
Camptothecinincreases expression1
Plant Extractsaffects cotreatment, decreases expression1
Tobacco Smoke Pollutiondecreases expression1
Tretinoindecreases expression1
Antirheumatic Agentsdecreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.